Renaxo Pharma Private Limited
About Renaxo Pharma Private Limited
Data last updated:
Renaxo Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 22 May 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2023PTC414538.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by directors Savitri and Manish Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 422 Blk – A Vats S, Harda Enclave Prem Nagar3, New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.76 Lakh, a growth of 103% compared to the previous year. For the same year it recorded a net profit of ₹4,685 (net margin 0.7%) and EBITDA of ₹6,325 (EBITDA margin 0.9%).
Company details
Contact details
Renaxo Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH. No. 422 Blk – A Vats S, Harda Enclave Prem Nagar3, New Delhi, Delhi, India – 110041
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Renaxo Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Renaxo Pharma Private Limited, buy the company report.
Financials of Renaxo Pharma Private Limited
FY 2025 filings availableRenaxo Pharma Private Limited reported revenue of ₹6.76 Lakh (up 103% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 103% in the latest year. EBITDA rose 63% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹6,325 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹4,685 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.9% | |
| Net Profit Margin | 0.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Renaxo Pharma Private Limited, buy the company report.
Board of directors of Renaxo Pharma Private Limited
Renaxo Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savitri | Director | 22 May 2023 | 3 Years 5 Months | Current |
| Manish Singh | Director | 22 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Renaxo Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shiv Shakti Bricks & Tiles Private Limited | ₹6.78 Lakh (FY 2023) | -75.0% | Ucknow, Uttar Pradesh, India | |||
| Manshi Textiles Private Limited | ₹6.77 Lakh (FY 2018) | 1375.0% | Kolkata, West Bengal, India | |||
| Weider World Protein Private Limited | ₹6.77 Lakh (FY 2023) | 76.0% | Baghpat, Uttar Pradesh, India | |||
| Im Stock & Sales Private Limited | ₹6.77 Lakh (FY 2024) | -54.0% | Bangalore, Karnataka, India | |||
| Digicraft Lifestyle Private Limited | ₹6.77 Lakh (FY 2025) | -53.0% | Delhi, India | |||
| Renaxo Pharma Private Limitedthis company | ₹6.76 Lakh (FY 2025) | ₹4,685 | 0.7% | 103.0% | New Delhi, Delhi, India | |
| Barrackpore Engineering & Services Private Limited | ₹6.76 Lakh (FY 2018) | 6.0% | Kolkata, West Bengal, India | |||
| B Mohan Electric Company Private Limited | ₹6.76 Lakh (FY 2025) | Delhi, India | ||||
| Tech Engineers Chai Bars Private Limited | ₹6.76 Lakh (FY 2023) | Jaipur, Rajasthan, India | ||||
| Mediavixx Digital Services (OPC) Private Limited | ₹6.76 Lakh (FY 2025) | 48310.0% | Sandila, Uttar Pradesh, India | |||
| Azentia Private Limited | ₹6.76 Lakh (FY 2025) | -15.0% | Valasaravakkam, Tamil Nadu, India |
To see the full peer comparison of Renaxo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Renaxo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Renaxo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Renaxo Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Renaxo Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Manish Singh was appointed as Director on 22 May 2023.
Frequently asked questions
Renaxo Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 22 May 2023 (3+ years old) and is registered under CIN U21001DL2023PTC414538.
Renaxo Pharma has 2 current directors:
- Savitri - Director
- Manish Singh - Director
The latest financial statements of Renaxo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Renaxo Pharma is U21001DL2023PTC414538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Renaxo Pharma was incorporated on 22 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Renaxo Pharma by revenue are Shiv Shakti Bricks & Tiles Private Limited, Manshi Textiles Private Limited, Weider World Protein Private Limited, Im Stock & Sales Private Limited, Digicraft Lifestyle Private Limited and 5 more, all in the same principal business activity (retail trading).
Manish Singh was appointed as Director on 22 May 2023. Savitri was appointed as Director on 22 May 2023.
The registered office of Renaxo Pharma is at H. No. 422 Blk – A Vats S, Harda Enclave Prem Nagar3, New Delhi, Delhi, India – 110041.
Renaxo Pharma operates in the paper industry, in the paper and paper products segment.
Renaxo Pharma can be reached at its registered office: H. No. 422 Blk – A Vats S, Harda Enclave Prem Nagar3, New Delhi, Delhi, India – 110041.
Renaxo Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
